ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, no model number
Published May 18, 2022 · Recall initiated: April 17, 2022
Summary
FDA records medical device Class II recall Z-1058-2022, published May 18, 2022 and initiated April 17, 2022. Recalling firm: PROTERIXBIO; Status: Terminated; Reported quantity: 640 kits; Lot: Lots were not coded. All product will be recalled. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FDA review concluded that the test is insufficiently supported by clinical performance data, and results reported may not have been accurate (false positives or false negatives).
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- PROTERIXBIO
- Distributor
- Domestic distribution to CA CO FL IA MA MO NH NY OH OK TX VA
- Lot
- Lots were not coded. All product will be recalled.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDA11005BC1 11005BCK1 Flexible Bronchoscope Z21493US-BA (06/2019)May 18, 2022
- FDAVITEK 2 Systems and VITEK 2 with MYLA.May 18, 2022
- FDABF-MP160F: EVIS EXERA BronchofibervideoscopeMay 18, 2022
- FDACYSTO-URETHRO-FIBERSCOPE REF 11272C1 CYSTOSCOPE, 15FR X 370MM, ADULT REF 11272C2 and Kit Number 11272CK2May 18, 2022
- FDABF-3C160: EVIS EXERA BronchovideoscopeMay 18, 2022
- FDA11278A2 11278AK2 Flexible Ureteroscope Z20615US-BA (08-2018); 11278AC1 N/A Flexible Ureteroscope Z17859US-AMay 18, 2022
Questions about this recall
Was ProterixBio SARS-CoV-2 (RBD) IgG Antibody Test, and associated ProterixBio Dried Blood Spot Collection Kit, no model number recalled?
Yes. FDA published recall Z-1058-2022 on May 18, 2022. Reported hazard: FDA review concluded that the test is insufficiently supported by clinical performance data, and results reported may not have been accurate (false positives or false negatives).
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail